Cesis, Latvia - Summer 2011 - Christopher Flach, Filmmaker and Artist is Featured in the 2011 Cesis Festival

Christopher Flach, filmmaker and artist, is featured in the 2011 Cesis Festival.

2011-08-31

NEW YORK, NY, August 31, 2011 (Press-News.org) With a great response from the audience Christopher Flach's film Madeleine Castaing, ended the last days of the Cesis Festival along with the final concert "Imants Kalnins and Philip Glass." Attended by more than 1800 visitors, this years 2011Festival contained a rich program featuring a diverse range of art forms included classical music concerts, visual art exhibitions, films and drama performances.

Christopher Flach's film "Madeleine Castaing," is the documentary that explores the personality and influence of the French decorator and antique dealer. The film celebrates Castaing's neoclassical taste in decor and her glamorous appearance even into her 90s. The film reintroduces her taste for Napoleon III furnishings and 18th century English furniture to collectors of art and design. Christopher Petkanas writes "Its a fountain of theatrical reminiscences."

About Christopher Flach
A New York City native, Flach spent his very early art career studying with Ansel Adams and Yousuf Karsh and more recently under the tutelage of Mary Ellen Mark. Co-founding Martha Angus, Inc., he re-located to Manhattan, opened a fine art studio, where he continues to photograph, document, film, and donate time and work to raise funds for the community.

To purchase the film "Madeleine Castaing" please contact the artist directly:
chris@chrisflach.com or 415-225-9476

2011 SLEEPLESS NIGHT MIAMI BEACH LINE-UP ANNOUNCED CHRISTOPHER FLACH's RETURN WITH HOURS OF STREAMING VIDEO WITH MORE TO COME.

Christopher's work will heat up the city from sundown to sunrise, November 5 - 6, 2011

http://sleeplessnight.org
http://www.cesufestivals.lv/eng
www.christopherflach.com
www.chrisflach.com
www.flachphotography.com
www.madeleinecastaing.com

[Attachments] See images for this press release:

ELSE PRESS RELEASES FROM THIS DATE:

Cardiac disease: Coronary or not?

2011-08-31

Acute myocardial Infarction (AMI) is a major cause of death and disability. Worldwide, one in eight patients die of an ischemic heart disease. Its rapid and accurate diagnosis is critical for the initiation of effective evidence based medical management, including early revascularization, but is still an unmet clinical need. The gradual implementation of high-sensitive cardiac troponins (hs-cTnT) in clinical practice has helped clinicians to detect and treat patients with acute myocardial infarction earlier than with conventional assays. But, high-sensitive assays have ...

Lower achieved platelet reactivity associated with better cardiovascular

2011-08-31

Compared to patients who had persistently high platelet reactivity, those who achieved low platelet reactivity, according to the VerifyNow P2Y12 Test, had a reduced incidence of cardiovascular death, heart attack and stent thrombosis, as indicated by a clinical trial presented today at the ESC Congress 2011. These findings were part of a secondary analysis of the Gauging Responsiveness with A VerifyNow P2Y12 Assay- Impact on Thrombosis and Safety (GRAVITAS) trial, the largest prospective trial to date to test the clinical efficacy of antiplatelet therapy modification, ...

Registry: Do medications which reduce angina

2011-08-31

Although medication which decreases the risk of angina attacks (chest pain caused by blockage of the arteries that supply the heart), are frequently prescribed in patients who have sustained a myocardial infarction, the possible influence of medication on long-term survival is not known, with the exception of beta-blocking agents, which have been shown to decrease mortality in clinical trials performed 30 years ago. Because antianginal drugs also protect the myocardium against ischemia (insufficient oxygen delivery to the heart muscle), there is a possibility that they ...

Transcatheter aortic valve implantation with the Edwards valve prosthesis in patients with low

2011-08-31

Results from a study presented today at the ESC Congress 2011, show that TAVI implantation in low risk patients, met with 100% procedural success (versus 95.3% in the high Euroscore group (p=0.1). "The most interesting point to observe is the absence of death at one month in the low Euroscore group, versus a mortality rate of 11.1% in the high Euroscore group (>20%), (p < 0.04) and this result is confirmed at 1-year with 5 vs 24.8 %, (p END ...

What do patients receiving optimal medical therapy after a heart attack die from?

2011-08-31

Because of improved management at the acute stage, the risk of dying in hospital after a heart attack has decreased by about 50% in the past 10 years. Likewise, the prescription of recommended medications when patients leave hospital, has resulted in improved survival and fewer recurrent heart attacks. One of the challenges is now to try and further decrease long-term mortality in patients who leave the hospital on "optimal" medical therapy (i.e. who are prescribed all the recommended medications). The French registry of Acute ST-elevation and non-ST-elevation Myocardial ...

Access Technology Solutions Named On the Utah Business Fast 50 List for the 4th Consecutive Year

2011-08-31

The rapid growth of global sales by leading U.S. companies has once again placed Access Technology Solutions in the international spotlight. For the fourth straight year, Utah Business magazine has ranked Access Technology Solutions among its top companies on the Utah Fast 50 list of the fastest-growing companies in Utah. The Utah Fast 50 program was designed to recognize companies for their entrepreneurial spirit, innovative business tactics and skyrocketing revenue growth. Access Technology Solutions was honored at an event in Salt Lake City on August 25th. Access' ...

New study shows patients with coronary artery disease

2011-08-31

Thrombotic (clotting) and bleeding events are complications that may occur after surgery. With the aging population in the western world, there are more patients undergoing orthopedic surgery than ever before. This makes understanding the risk of complications from orthopedic surgery exceedingly important. However, there is a lack of data investigating the incidence of thrombotic and bleeding complications in orthopedic surgery. The new study by investigators at NYU School of Medicine was comprised of 3,082 patients undergoing orthopedic surgery of the hip, knee, and ...

ESC pilot registry in heart failure reflects improvement in chronic disease

2011-08-31

With the increased prevalence of chronic heart failure (HF), there is a concomitant increase in the number of related hospitalisations; as chronic HF progresses, the risk of acute exacerbation increases. Registries and surveys of HF have been generally conducted in patients with either chronic or acute conditions, but a description of the whole clinical history of patients with HF, including the acute episodes, consequent changes in clinical conditions and management strategies, have not been available. The final results of the Heart Failure Pilot Study, a general ...

Dentist in Lodi Recommends Dental Implants for Residents Seeking an Attractive Smile

2011-08-31

Bergen County, New Jersey Dentist Dr. Sherzoy is a well qualified Cosmetic Dentist who has helped his patients restore their smiles, beauty and self-confidence with Dental Implants. Dental Implants are a proven and effective solution for people who have damaged or missing teeth who find themselves embarrassed about their smiles and want a smile restoration. Dr. Sherzoy is well qualified in the field of Implant Dentistry, a specialized aspect of dentistry, dealing with the placement and restoration of dental implants. Dental Implants are Dr. Sherzoy's preferred method ...

The first European registry to evaluate the real-life epidemiology of atrial fibrillation ablation

2011-08-31

Results presented today from the Atrial Fibrillation Ablation Pilot Study show that almost 40% of patients undergoing a catheter ablation for atrial fibrillation have no underlying disease associated with the arrhythmia, and precipitating factors are rare. The survey, which is a pilot survey from the ESC's EurObservational registry programme, also confirmed that symptoms are present in 86% of patients but vary considerably; symptoms include palpitations, fatigue, and shortness of breath or dizziness. "The AFib Ablation Pilot Study shows that, while symptoms remain the ...

LAST 30 PRESS RELEASES:

Patrick Tan appointed as Duke-NUS Dean to lead next era of medical innovation and education

Development of a novel modified selective medium cefixime–tellurite-phosphate-xylose-rhamnose MacConkey agar for isolation of Escherichia albertii and its evaluation with food samples

KIST develops full-color-emitting upconversion nanoparticle technology for color displays with ultra-high color reproducibility

Towards a fully automated approach for assessing English proficiency

Increase in alcohol deaths in England an ‘acute crisis’

Government urged to tackle inequality in ‘low-carbon tech’ like solar panels and electric cars

Moffitt-led international study finds new drug delivery system effective against rare eye cancer

Boston stroke neurologist elected new American Academy of Neurology president

Center for Open Science launches collaborative health research replication initiative

Crystal L. Mackall, MD, FAACR, recognized with the 2025 AACR-Cancer Research Institute Lloyd J. Old Award in Cancer Immunology

A novel strategy for detecting trace-level nanoplastics in aquatic environments: Multi-feature machine learning-enhanced SERS quantification leveraging the coffee ring effect